期刊文献+

重组人基质金属蛋白酶2(MMP-2)血红素样蛋白表达优化

Optimization of expression conditions of recombinant human-source matrix metalloproteinase 2 hemopexin-like C-terminal domain
下载PDF
导出
摘要 为确定重组大肠杆菌(BL21(DE3)/PET42a-PEX)最佳表达条件。在单因素实验的基础之上,以目的蛋白PEX表达量为响应值,应用Box-Behnken中心组合设计建立数学模型,进行响应面分析。响应面分析确定的最优因素水平组合为:LB培养基pH为7.50,诱导时菌液OD600为0.60,IPTG诱导浓度为0.60mmol/L,诱导培养时间为5.0h。对此工艺条件进行验证得到目的蛋白PEX表达量为20.98mg/L。结果显示,优化了基因重组大肠杆菌表达人PEX的条件,为实现基因重组原核工程菌发酵法制备重组PEX奠定了基础。 To optimize fermentation conditions of Genetically Engineered Escherichia coli(BL21(DE3)/PET42a-PEX),Box-Behnken design was used to establish mathematical model based on single-factor tests.The response surface methodology(RSM) analysis result showed that the optimal scale of factors was:Luria-Bertani liquid culture medium pH7.50,bacterial liquid optical density(OD600) 0.60,induce concentration of IPTG 0.60mmol/L,induce time 5.0h.Under these optimized conditions,the yield of PEX was 20.98mg/L.Optimization of expression conditions of genetically engineered Escherichia coli expressing recombinant human-source matrix metalloproteinase 2 hemopexin-like C-terminal domain was studied,and laid the foundation of generation of human recombinant PEX by fermentation.
出处 《食品工业科技》 CAS CSCD 北大核心 2012年第22期248-250,259,共4页 Science and Technology of Food Industry
基金 教育部科学技术研究重点项目(211150) 重庆三峡学院项目(2008-sxxyqn-31)
关键词 大肠杆菌 基质金属蛋白酶2 血红素样蛋白 BOX-BEHNKEN设计 Escherichia coli matrix metalloproteinase 2 hemopexin-like C-terminal domain Box-Behnken design
  • 相关文献

参考文献16

  • 1Brigitte B. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers:Outside-in signaling and relationship to tumor progression [J]. Reviews on Cancer, 2012,1825 ( 1 ) : 29-36.
  • 2Visser,Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases : structure, function and biochemistry [J]. Circulation Research, 2003,92 (8) : 827-839.
  • 3Amalinei C,Caruntu D,Balan RA. Biology of metalloproteinases [J]. Romanian Journal of Morphology and Embryology,2007,48 (4) :323-334.
  • 4Jezierska A, Motyl T. Matrix metalloproteinase-2 involvement in breast cancer progression:a mini-review[J]. Medical Science Monitor, 2009,15 (2) : 32-40.
  • 5Homas P,Lozito,Rocky ST. Endothelial cell mieropartieles act as centers of matrix metalloproteinsase-2(MMP-2) activation and vascular matrix remodeling[J]. Journal of Cellular Physiology, 2012,227 : 534-549.
  • 6Elizabeth F, Amato J, Giaccia. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease[J]. Cancer and Metastasis Reviews, 2010,29 (2) : 285-293.
  • 7Zucker S,Cao .I. Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy[J]. Cancer Biology and Therapy,2009,24(8) :2371-2373.
  • 8Dimitra B,William G,Stetler S. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion[J]. Seminars in Cancer Biology,2010,20(3) : 161-168.
  • 9Janelle LF,Michael J,Chalmers SA,et al. Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity[J]. The Journal of Biological Chemistry, 2009,284 (36) : 24017-24024.
  • 10Kai K,Vieki P, Zena W. Matrix metalloproteinases : regulators of the tumor microenvironment[J]. Cell, 2010,141 ( 1 ) : 52-67.

二级参考文献10

  • 1Munoz-Najar U M,Neurath K M.Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation[J].Oncogene,2006,25 (16):2379 -2392.
  • 2Mook O R,Frederiks W M,Van Noorden C J.The role of gelatinases in colorectal cancer progression and metastasis[J].Biochim Biophys Acta,2004,1705(2):69-89.
  • 3Kubben F J,Sier C F,van Duijn W,et al.Matrix metallo-proteinase-2 is a consistent prognostic factor in gastric cancer[J].Br J Cancer,2006,94(7):1035- 1040.
  • 4Brooks P C,Silletti S,von Schalscha T L,et al.Disruption of angiogenesis by PEX,anoncatalytic metalloproteinase fragment with integrin binding activity[J].Cell,1998,92(6):391-400.
  • 5Bello L,Lucini V,Carrabba G,et al.Simultaneous inhibition of glioma angio-genesis,cell pro-liferation,and invasion by a naturally occurring fragment of human metalloproteinase-2[J].Cancer Research,2001,61(12):8730-8736.
  • 6Penkowa M.Metallothioneins are multipurpose neuroprotectants during brain pathology[J].FEBS J,2006,73 (9):1857-1870.
  • 7Lemaitre V,DArmiento J.Matrix metalloproteinases in development and disease[J].Birth Defects Res C Embryo Today,2006,78(1):1-10.
  • 8Malemud C J.Matrix metalloproteinases (MMPs) in health and disease:an overview[J].Front Biosci,2006,11:1696-701.
  • 9李金萍,张光谋,柯杨,林本耀,赵威,胡颖,宁涛,林仲翔,张志谦.基质金属蛋白酶-2C端片段PEX的原核表达及其对血管发生的抑制作用[J].生物化学与生物物理进展,2002,29(1):120-123. 被引量:10
  • 10许传杰,李玉林,李一雷,高洪文.基质金属蛋白酶-2C端片段pex的克隆、测序及真核表达载体的构建[J].吉林大学学报(医学版),2003,29(5):591-593. 被引量:2

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部